Compare · MRAI vs VMD
MRAI vs VMD
Side-by-side comparison of Marpai Inc. (MRAI) and Viemed Healthcare Inc. (VMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MRAI and VMD operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- VMD is the larger of the two at $377.0M, about 8.7x MRAI ($43.5M).
- Both names hit the wire about 4 times in the past 4 weeks.
- VMD has more recent analyst coverage (1 ratings vs 0 for MRAI).
- Company
- Marpai Inc.
- Viemed Healthcare Inc.
- Price
- $0.92-55.67%
- $9.84-15.75%
- Market cap
- $43.5M
- $377.0M
- 1M return
- -
- -18.95%
- 1Y return
- -
- +55.70%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 4
- 4
- Recent ratings
- 0
- 1
Marpai Inc.
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market. It also offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. The company was incorporated in 2021 and is based in Tampa, Florida.
Viemed Healthcare Inc.
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
Latest MRAI
- Marpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Marpai Announces $12 Million Private Placement led by Mitchell Companies
- Marpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity
- Director Eitan Yaron returned 50,000 shares to the company and was granted 175,000 shares, decreasing direct ownership by 4% to 1,224,073 units (SEC Form 4)
- Chief Financial Officer Johnson Steve Andrew was granted 125,000 shares and bought $682 worth of shares (1,100 units at $0.62), increasing direct ownership by 14% to 1,024,192 units (SEC Form 4)
- Director Shiv Sagiv returned 50,000 shares to the company and was granted 125,000 shares, decreasing direct ownership by 8% to 613,667 units (SEC Form 4)
- Director Pons Robert M returned 50,000 shares to the company and was granted 100,000 shares, decreasing direct ownership by 9% to 484,200 units (SEC Form 4)
- Director Calabrese Jennifer Rosario returned 50,000 shares to the company and was granted 100,000 shares, decreasing direct ownership by 18% to 225,000 units (SEC Form 4)
- Chief Executive Officer Lamendola Damien was granted 300,000 shares, increasing direct ownership by 22% to 1,650,000 units (SEC Form 4)
Latest VMD
- SEC Form 10-Q filed by Viemed Healthcare Inc.
- Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Viemed Healthcare Announces Second Quarter 2026 Financial Results
- Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
- Chief Medical Officer Frazier William exercised 10,000 shares at a strike of $1.81 and sold $117,200 worth of shares (10,000 units at $11.72) (SEC Form 4)
- Director Smokoff Timothy sold $229,967 worth of shares (20,000 units at $11.50), decreasing direct ownership by 21% to 75,518 units (SEC Form 4)
- Viemed Healthcare Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Viemed Healthcare Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by Viemed Healthcare Inc.
- Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits